Keyphrases
Tumor
100%
Epigenetic Control
100%
Non-coding RNA (ncRNA)
100%
Sphenoid Sinus
100%
Primary Ewing Sarcoma
100%
Intracranial Extension
100%
Rare Case Report
100%
Sinonasal Tract
100%
Autophagy
100%
Ethmoid Sinus
100%
Venous Thromboembolism
100%
Day Hospital
100%
Italy
100%
Chemotherapy
100%
Oncology
100%
Retrospective Analysis
100%
Non-small Cell Lung Cancer Patients
100%
Kinase Inhibitor
100%
Diacylglycerol Kinase
100%
Pharmacophoric
100%
Structure-activity Relationship Studies
100%
Non-small Cell Lung Cancer (NSCLC)
83%
Ewing Sarcoma
75%
Extraskeletal
50%
Cytokeratin
50%
Cancer Patients
36%
Thromboprophylaxis
33%
CDDP
33%
Deep Vein Thrombosis
33%
Advanced Stage
33%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
33%
Disease Stage
33%
Adenocarcinoma
33%
6-cycles
25%
Male Patients
25%
CD99
25%
Epistaxis
25%
Quality of Life
25%
Research Biopsy
25%
Microscopic Examination
25%
First-line Chemotherapy
25%
Clinical Examination
25%
Fluorescence in Situ Hybridization
25%
Disease Progression
25%
Restaging
25%
Magnetic Resonance Imaging
25%
Localized Disease
25%
Visual Acuity
25%
Neuron-specific Enolase
25%
CD56
25%
Medicine and Dentistry
Sphenoidal Sinus
100%
Ethmoid Sinus
100%
Ewing Sarcoma
100%
Oncology
100%
Venous Thromboembolism
100%
Non Small Cell Lung Cancer
100%
Chemotherapy
100%
Thromboembolism
28%
Deep Vein Thrombosis
28%
Adenocarcinoma
28%
Lung Cancer
28%
Epistaxis
25%
Clinical Examination
25%
Anterior Cranial Fossa
25%
Carcinoma
25%
Neck
25%
Neoplasm
25%
Visual Acuity
25%
Magnetic Resonance Imaging
25%
Cytokeratin
25%
Fluorescence in Situ Hybridization
25%
Headache
25%
Neuron Specific Enolase
25%
Functional Status
25%
Disease Exacerbation
25%
Magnetic Resonance Imaging of the Brain
25%
Anosmia
25%
First-Line Chemotherapy
25%
Surgery
25%
Periodic Acid-Schiff Stain
25%
Radiation Therapy
25%
Second-Line Chemotherapy
25%
Synaptophysin
25%
Endoscope
25%
Microscopy
25%
Recurrent Disease
25%
Vimentin
25%
Quality of Life
25%
Biopsy Technique
25%
Malignant Neoplasm
14%
Clinical Trial
14%
Disease
14%
Thromboprophylaxis
14%
Outpatient
14%
Cancer Therapy
14%
Chemotherapy Regimens
14%
Central Venous Catheter
14%
Combination Therapy
14%
Acetylsalicylic Acid
14%
Small Cell Lung Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Venous Thromboembolism
100%
Non Small Cell Lung Cancer
100%
Diacylglycerol Kinase Inhibitor
100%
Structure Activity Relationship
100%
Malignant Neoplasm
67%
Thromboembolism
28%
Deep Vein Thrombosis
28%
Adenocarcinoma
28%
Lung Cancer
28%
Lymphoproliferative Disease
25%
IC50
25%
Virtual Screening
25%
Diacylglycerol Kinase
25%
Serotonin Receptor
25%
Gene Targeting
20%
Acetylsalicylic Acid
14%
Chemotherapy Regimens
14%
Combination Therapy
14%
Small Cell Lung Cancer
14%
Large Cell Carcinoma
14%
Cisplatin
14%
Clinical Trial
14%
Disease
14%
Erythropoietin
14%
Squamous Cell Carcinoma
14%
Low Molecular Weight Heparin
14%
Anticoagulant Agent
14%